Abstract
Disturbances in the circadian rhythms have long been associated with depression and mania. Animal models of mania and depression exhibit differential effects upon the intrinsic circadian period and the same occurs with antidepressants and mood stabilizers treatment. The intrinsic circadian period is expressed when there are no time clues or when the light/dark cycle length is beyond the capacity of synchronization. In summary, while there is no clear association between the circadian period and mania, depressive-like behaviour is generally associated either with lengthening of the circadian period or with arrythmicity, and the improvement of depressive-like behaviour is associated with shortening of the circadian period. Thus, this review is an attempt to summarize data regarding these correlations and find a putative role of the circadian intrinsic period in mood regulation, particularly concerning the switch from depression to mania.
Keywords: Antidepressants, bipolar disorder, depression, endogenous circadian period, mania, mood stabilizers.
CNS & Neurological Disorders - Drug Targets
Title:Stretch, Shrink, and Shatter the Rhythms: The Intrinsic Circadian Period in Mania and Depression
Volume: 14 Issue: 8
Author(s): Bruno Jacson Martynhak, Marcela Pereira, Camila Pasquini de Souza and Roberto Andreatini
Affiliation:
Keywords: Antidepressants, bipolar disorder, depression, endogenous circadian period, mania, mood stabilizers.
Abstract: Disturbances in the circadian rhythms have long been associated with depression and mania. Animal models of mania and depression exhibit differential effects upon the intrinsic circadian period and the same occurs with antidepressants and mood stabilizers treatment. The intrinsic circadian period is expressed when there are no time clues or when the light/dark cycle length is beyond the capacity of synchronization. In summary, while there is no clear association between the circadian period and mania, depressive-like behaviour is generally associated either with lengthening of the circadian period or with arrythmicity, and the improvement of depressive-like behaviour is associated with shortening of the circadian period. Thus, this review is an attempt to summarize data regarding these correlations and find a putative role of the circadian intrinsic period in mood regulation, particularly concerning the switch from depression to mania.
Export Options
About this article
Cite this article as:
Martynhak Jacson Bruno, Pereira Marcela, de Souza Pasquini Camila and Andreatini Roberto, Stretch, Shrink, and Shatter the Rhythms: The Intrinsic Circadian Period in Mania and Depression, CNS & Neurological Disorders - Drug Targets 2015; 14 (8) . https://dx.doi.org/10.2174/1871527314666150909115203
DOI https://dx.doi.org/10.2174/1871527314666150909115203 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
GMP-Automated Purification of Copper-61 Produced in Cyclotron Liquid Targets: Methodological Aspects
Current Radiopharmaceuticals Current Treatment Strategies for Multiple Sclerosis - Efficacy Versus Neurological Adverse Effects
Current Pharmaceutical Design Blood Brain Barrier Compromise with Endothelial Inflammation may Lead to Autoimmune Loss of Myelin during Multiple Sclerosis
Current Neurovascular Research Quinazolinone Analogs as Potential Therapeutic Agents
Current Medicinal Chemistry Modulation of Neurotransmitter Release by Carbon Monoxide at the Frog Neuro-Muscular Junction
Current Drug Metabolism Monoterpenes as Perspective to Chronic Pain Management: A Systematic Review
Current Drug Targets Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors
Current Topics in Medicinal Chemistry The Comorbidity of Bipolar Disorder and Migraine: The Role of Inflammation and Oxidative and Nitrosative Stress
Current Molecular Medicine Brain Inflammation Following Intracerebral Hemorrhage
Current Neuropharmacology Oxidative Stress in Autoimmune Diseases: An Under Dealt Malice
Current Protein & Peptide Science Glycogen Synthase Kinase-3 (GSK3) in Psychiatric Diseases and Therapeutic Interventions
Current Drug Targets Recent Advances in the Pharmacotherapeutic Management of Drug Dependence and Addiction
Current Psychiatry Reviews Combination Therapy for Multi-Target Manipulation of Secondary Brain Injury Mechanisms
Current Neuropharmacology Nitrergic Response to Clostridium perfringens Infection in the Rat Brain Regions Effect of Red Light Irradiation
Central Nervous System Agents in Medicinal Chemistry Energy Balance and Carcinogenesis: Underlying Pathways and Targets for Intervention
Current Cancer Drug Targets The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression
Current Signal Transduction Therapy Human Amniotic Fluid Stem Cells as an Attractive Tool for Clinical Applications
Current Stem Cell Research & Therapy Family B G Protein-coupled Receptors and their Ligands: From Structure to Function
Current Medicinal Chemistry Cannabis: An Overview of its Adverse Acute and Chronic Effects and its Implications
Current Drug Abuse Reviews Dysfunction of Endoplasmic Reticulum (ER) and Mitochondria (MT) in Alzheimer's Disease: The Role of the ER-MT Cross-Talk
Current Alzheimer Research